1. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I‐III stage CRC. Issue 5 (30th September 2016) Authors: Peng, Hong‐Xin; Yang, Lin; He, Bang‐Shun; Pan, Yu‐Qin; Ying, Hou‐Qun; Sun, Hui‐Ling; Lin, Kang; Hu, Xiu‐Xiu; Xu, Tao; Wang, Shu‐Kui Journal: Journal of clinical laboratory analysis Issue: Volume 31:Issue 5(2017:Sep.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MiR‐142‐3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer. Issue 5 (31st October 2019) Authors: Xu, Tao; He, Bang‐Shun; Pan, Bei; Pan, Yu‐Qin; Sun, Hui‐Ling; Liu, Xiang‐Xiang; Xu, Xue‐Ni; Chen, Xiao‐Xiang; Zeng, Kai‐Xuan; Xu, Mu; Wang, Shu‐Kui Journal: Journal of cellular physiology Issue: Volume 235:Issue 5(2020:May) Page Start: 4928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Platelet‐to‐lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta‐analysis. Issue 7 (16th June 2016) Authors: Peng, Hong‐Xin; Lin, Kang; He, Bang‐Shun; Pan, Yu‐Qin; Ying, Hou‐Qun; Hu, Xiu‐Xiu; Xu, Tao; Wang, Shu‐Kui Journal: FEBS open bio Issue: Volume 6:Issue 7(2016) Page Start: 742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole‡. (11th February 2015) Authors: Pan, Yu‐Qin; Mi, Qiong‐Yu; He, Bang‐Shun; Zhao, Shu‐Li; Tai, Ting; Xie, Hong‐Guang Journal: Biopharmaceutics & drug disposition Issue: Volume 36:Number 4(2015:May) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗